Unit of Endocrinology and Metabolic Diseases, Luigi Vanvitelli University of Campania, Naples, Italy -
Unit of Endocrinology and Metabolic Diseases, Luigi Vanvitelli University of Campania, Naples, Italy.
Q J Nucl Med Mol Imaging. 2021 Jun;65(2):113-123. doi: 10.23736/S1824-4785.21.03334-3. Epub 2021 Jan 26.
Medical treatment is the primary therapeutic option for thyrotoxicosis/hyperthyroidism. Two groups of causes of thyrotoxicosis (i.e. thyrotoxicosis with hyperthyroidism and thyrotoxicosis without hyperthyroidism) need to be considered for therapeutic reasons. Herein we provide an updated review on the role of conventional medical therapies (i.e. β-blockers, antithyroid drugs [ATDs], corticosteroids, inorganic iodide, perchlorate, cholecystographic agents, lithium, cholestyramine) in the main causes of thyrotoxicosis, starting from the rationale subtending their clinical application.
治疗是治疗甲状腺毒症/甲状腺功能亢进的主要治疗选择。出于治疗的原因,需要考虑两种甲状腺毒症的病因(即伴有甲状腺功能亢进的甲状腺毒症和不伴有甲状腺功能亢进的甲状腺毒症)。本文从其临床应用的基本原理出发,对常规医学治疗(即β受体阻滞剂、抗甲状腺药物[ATD]、皮质类固醇、无机碘、高氯酸盐、胆囊造影剂、锂、考来烯胺)在主要甲状腺毒症病因中的作用进行了更新综述。